The Ensign Group (NASDAQ:ENSG) Given New $207.00 Price Target at Truist Financial

The Ensign Group (NASDAQ:ENSG) had its price objective upped by Truist Financial from $202.00 to $207.00 in a research note published on Thursday,Benzinga reports. They currently have a hold rating on the stock.

A number of other brokerages have also recently issued reports on ENSG. Weiss Ratings cut The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $228.00 price target on shares of The Ensign Group in a research report on Tuesday. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, The Ensign Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $216.25.

The Ensign Group Price Performance

Shares of NASDAQ ENSG opened at $178.83 on Thursday. The Ensign Group has a fifty-two week low of $141.58 and a fifty-two week high of $218.00. The company has a 50 day simple moving average of $165.69 and a two-hundred day simple moving average of $184.00. The company has a market capitalization of $10.42 billion, a price-to-earnings ratio of 28.03, a P/E/G ratio of 1.78 and a beta of 0.69. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.21.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.12. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business’s revenue was up 16.7% on a year-over-year basis. During the same period last year, the business earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Analysts expect that The Ensign Group will post 6.82 EPS for the current fiscal year.

The Ensign Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend is Tuesday, June 30th. The Ensign Group’s dividend payout ratio is presently 4.08%.

Insider Buying and Selling at The Ensign Group

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the completion of the transaction, the director owned 9,503 shares of the company’s stock, valued at approximately $1,625,583.18. The trade was a 3.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. This trade represents a 3.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,792 shares of company stock worth $309,599 over the last ninety days. 4.00% of the stock is currently owned by insiders.

Institutional Trading of The Ensign Group

Institutional investors have recently made changes to their positions in the stock. Private Trust Co. NA raised its holdings in shares of The Ensign Group by 156.5% during the fourth quarter. Private Trust Co. NA now owns 159 shares of the company’s stock valued at $28,000 after purchasing an additional 97 shares during the last quarter. Monetary Solutions Ltd purchased a new stake in The Ensign Group in the fourth quarter worth approximately $30,000. Northwestern Mutual Wealth Management Co. boosted its holdings in The Ensign Group by 55.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock worth $30,000 after purchasing an additional 61 shares during the last quarter. Bayban bought a new stake in The Ensign Group in the 4th quarter worth approximately $31,000. Finally, Cedar Mountain Advisors LLC purchased a new stake in The Ensign Group during the 1st quarter valued at $32,000. Hedge funds and other institutional investors own 96.12% of the company’s stock.

More The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Q2 results exceeded expectations: Ensign reported adjusted EPS of $1.92, above the $1.80 consensus, while revenue reached approximately $1.44 billion and increased 16.7% year over year. Growth was supported by higher occupancy, patient days and contributions from acquired facilities. ENSG Q2 Earnings Beat Estimates
• Positive Sentiment: 2026 outlook was raised: Management increased full-year adjusted EPS guidance to $7.75–$7.85, signaling continued confidence in occupancy trends, facility growth and operating performance.
• Positive Sentiment: Truist raised its price target: Truist Financial lifted its target from $202 to $207, although it retained a “hold” rating. The revision provides valuation support but reflects a more cautious view than a bullish upgrade. Truist raises ENSG price target
• Neutral Sentiment: Insider transaction: Director John Agwunobi sold 392 shares worth about $67,056 under a pre-arranged Rule 10b5-1 plan. The relatively small, planned sale reduces its value as a bearish signal.
• Negative Sentiment: Legal overhang intensified: Rosen Law Firm announced an investigation into allegations that Ensign may have issued materially misleading business information. The announcement follows similar investigations by Kaplan Fox and Bleichmar Fonti & Auld, creating potential litigation, regulatory and reputational risks. The allegations have not been proven. Rosen Law Firm Ensign investigation

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.